Andere talen PTC Therapeutics, Inc.

Aandelen

PTCT

US69366J2006

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
25,49 ^USD	+1,11%		+3,24%	-7,51%

25/04	PTC Therapeutics, Inc. rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
25/04	Transcript : PTC Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

PTC Therapeutics : Q1 2024 FLS	25/04
PTC Therapeutics: Q1 Earnings Snapshot	25/04
Earnings Flash (PTCT) PTC THERAPEUTICS Posts Q1 Revenue $210.1M, vs. Street Est of $163.8M	25/04
PTC Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results	25/04
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	24/04
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23/04
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results	12/04
PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results	11/04
PTC Therapeutics Seeks EMA Marketing Authorization for Sepiapterin for Phenylketonuria Treatment	28/03
PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA	28/03
PTC Therapeutics, Inc. Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA	28/03
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza as a Treatment for AADC Deficiency	20/03
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza? as a Treatment for AADC Deficiency	19/03
PTC Therapeutics Provides Key Regulatory Updates	19/03
PTC Therapeutics Shares Jump Following Q4 Results	01/03
PTC Therapeutics Q4 Loss Narrows, Sales Up; Sets Guidance; Shares Slump After-Hours	29/02
PTC Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
PTC Therapeutics: Q4 Earnings Snapshot	29/02
PTC Therapeutics, Inc. Provides Earnings Guidance for the Year 2024	29/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen PTC Therapeutics, Inc.

Aandelen

PTCT

US69366J2006

Andere talen

Filters